Anti-tuberculosis therapy as a reason for ejaculatory disorders

E. Kulchavenya, E. Brizhatyuk, D. Kholtobin, A. Osadchyi (Novosibirsk, Russian Federation)

Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Session: Tuberculosis: clinical findings II
Session type: Thematic Poster Session
Number: 2606
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Kulchavenya, E. Brizhatyuk, D. Kholtobin, A. Osadchyi (Novosibirsk, Russian Federation). Anti-tuberculosis therapy as a reason for ejaculatory disorders. Eur Respir J 2012; 40: Suppl. 56, 2606

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Noncompliance on antituberculosis treatment and the psychological profile
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001

Problems of treatment of TB patients suffering from alcohol and drugs addiction
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002

The effectiveness of TB treatment in patients with gastrointestinal tract disorders, depending on the way of administration of anti-TB drugs
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


The side-effects of TB therapy: myth and reality
Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties
Year: 2005


DOTS-Plus treatment of MDR-TB patients with psychiatric disorders
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


Withdrawal symptoms in psychiatric patients treated with varenicline
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008


Second-line injectables: are they essential to treat MDR/XDR-TB cases?
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008



Influence of psychiatric disorders in patients treated with Varenicline.
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017


Drug-induced sleep endoscopy predictors for oral appliance treatment outcome
Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing
Year: 2013

The efficacy and side-effects of varenicline in patients with pneumologic diseases
Source: Annual Congress 2009 - Smoking cessation
Year: 2009



Use of relievers in patients with severe asthma on biologic therapy –a multidisciplinary approach
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020


Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Can we really relieve the withdrawal syndrome with pharmacotherapy in smoking cessation?
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012


First-line therapy
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Bronchial asthma as neurogenic inflammatory and paroxysmal disease – efficacy of antiepileptic drug diphenine in asthma therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 316s
Year: 2006

Is surgical treatment a motivator factor for smoking cessation? Experience in an anticancer hospital
Source: International Congress 2015 – Smoking cessation
Year: 2015


Self-care behavior for medications use and treatment outcome in elderly with asthma
Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems
Year: 2010


Paradox radiologic progression despite appropriate antituberculosis therapy
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011

Reasons for hepatotoxic reactions to chemotherapeutic agents and possibilities of their prevention in adolescents with tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 468s
Year: 2001